Alterity Therapeutics Limited (ATHE)

Alterity Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Year Ending	Current	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Market Capitalization	14	11	22	44	12	18
Market Cap Growth	-18.58%	-47.27%	-50.72%	259.32%	-30.44%	0.74%
Enterprise Value	6	-5	-4	17	4	12
Last Close Price	2.49	2.79	6.11	13.00	11.90	13.10
PE Ratio	-	-737.83	-1661.54	-1921.90	-1146.24	-932.48
PS Ratio	5.72	4.36	6.11	13.45	-	5.04
PB Ratio	1.24	0.75	0.88	1.92	2.47	1.51
P/FCF Ratio	-1.34	-0.85	-2.52	-3.37	-1.87	-1.79
P/OCF Ratio	-1.34	-0.85	-2.54	-3.37	-1.87	-1.79
EV/Sales Ratio	1.18	-2.09	-1.11	5.37	-	3.35
EV/EBITDA Ratio	-0.32	0.56	0.37	-1.54	-0.39	-1.30
EV/EBIT Ratio	-0.31	0.56	0.37	-1.54	-0.39	-1.30
EV/FCF Ratio	-0.28	0.41	0.46	-1.34	-0.58	-1.19
Debt / Equity Ratio	0.01	0.01	0.00	0.00	0.00	-
Debt / FCF Ratio	-0.02	-0.01	-0.01	0.00	0.00	-
Asset Turnover	0.12	0.11	0.14	0.20	-	0.26
Quick Ratio	4.07	5.58	6.79	10.56	3.41	5.79
Current Ratio	4.90	6.17	7.07	10.92	3.62	5.98
Return on Equity (ROE)	-53.72%	-47.38%	-38.97%	-81.39%	-113.53%	-75.61%
Return on Assets (ROA)	-28.94%	-26.64%	-25.85%	-43.62%	-58.40%	-41.40%
Return on Capital (ROIC)	-34.91%	-31.22%	-29.31%	-50.30%	-73.35%	-49.01%
Earnings Yield	-58.52%	-80.84%	-41.06%	-26.24%	-76.31%	-49.42%
FCF Yield	-67.02%	-117.35%	-39.71%	-29.72%	-53.57%	-55.93%
Buyback Yield / Dilution	-1.37%	-0.91%	-41.79%	-89.62%	-45.33%	-15.34%
Total Shareholder Return	-1.37%	-0.91%	-41.79%	-89.62%	-45.33%	-15.34%

Source: S&P Capital IQ. Standard template.